• Home
  • About Us
    • Who we are
    • Our Early History
    • Technology
    • Target Markets
      • Venous and pressure ulcers
      • Other Applications
    • Business Model
    • Licensing
    • Clinical Trial
    • Publications & Presentations
    • Company Milestones
    • Focus
  • The Company
    • Board & Management
      • Paul Wright
      • Mark Richardson
      • George Baumanis
      • Stuart Usher
  • Advisory Team
    • Intellectual Property
      • Vaughan Barlow
      • Tom Boyce
      • Audrey Yap
      • Yvette Flanigan
    • Principal Advisor
      • Mark Woolley
    • Medical and Scientific Advisory Committee
      • James Fries
      • Michael Woodward
    • Scientific
      • Richard Lipscombe
    • Clinical
      • Geoffrey Mitchell
    • Health Economics
      • Nicholas Graves
  • Media
  • Links
  • Members Log in
  • Contact Us

News Headlines

> 18/01/10
Phoenix Eagle commences clinical trial.


> 01/12/09
OPAL A-1001 clinical trial has been approved by the Human Research Ethics Committee of the Austin Hospital.

The Phoenix Eagle Advisory Team

Intellectual Property - Yvette Flanigan

Yvette Flanigan, PhD, is a Senior Patent Associate at Yu Sarn Audrey & Partners and is directly responsible for the prosecution of Phoenix Eagle’s patent applications in the Asian jurisdictions. Yvette has a Bachelor of Science with first class honours and a Ph.D. in the field of biochemistry. She also has a Graduate Certificate in Intellectual Property Law from the National University of Singapore and a certificate in patent drafting by the Southeast Asian Drafting Patents Board of FICPI. Prior to commencing her career in IP law, Yvette worked as a research scientist at Dupont Singapore; at the National University of Singapore; Nanyang Technological University and at the University of Queensland.

The Phoenix Eagle Company Pty Ltd website is proudly maintained by NetBiz Enterprises.